Bristol Myers Squibb

Since Scripps and Bristol Myers Squibb began their long-term, multi-laboratory partnership in 2012, BMS medicinal, process, radiochemistry and discovery scientists have co-authored more of our papers than any other company, from the first kilogram-ready bromination of N-oxides to P(V) oligonucleotide chemistry, electrocatalytic cross-coupling and sulfonyl hydrazides. Martin Eastgate’s patience and optimism, the 2015 Account records, rescued a project that was very nearly abandoned. Many of our alumni now do their chemistry at BMS, and several have returned to our papers as partners.

Princeton, New Jersey

Papers together
52
Years
2013–present
Co-authors
96
The record

All 52 papers with Bristol Myers Squibb

All partners →
  1. A Kinetics-First Approach Reveals Optimum Vinylaminopyrimidines for Cysteine-Based Antibody Conjugation

    ChemRxiv 2026Preprint · doi:10.26434/chemrxiv.15006704/v1 · In our publications

    • Bristol Myers Squibb Ailing Li, Bin Zheng, Donggeon Nam, Drexler Dieter, Emily Lee, Eric R. Welin, Helen L. Evans, Hong Zhang, Juhi Juneja, Michael A. Schmidt, Monir Ejemel, Nicole Vincent Jordan, Paul M. Scola, Ruchita Rajendra Thakore, Sayumi Yamazoe, Stephen E. Mercer, Wade Wang, Yaxing Zhu, Younhee Cho, Zach Parsons
  2. Highly Chemoselective Access to Alkyl-Sulfur Compounds via N2 Extrusion of Alkyl Hydrazines

    Nat. Chem. 2026 · doi:10.1038/s41557-026-02212-8 · In our publications

    • Bristol Myers Squibb Martins S. Oderinde
    • Chemveda Life Sciences Nangunoori Sampath Kumar, Ramana Murthy, Thirupathi Gogula
  3. Triply Convergent Ni-Electrocatalytic Assembly of 1,1-Diaryl Cyclobutanes, Azetidines and Oxetanes

    Nat. Chem. 2026 · doi:10.1038/s41557-025-01990-x · In our publications

    • Bristol Myers Squibb Martins S. Oderinde, Maximilian D. Palkowitz, Megan A. Emmanuel, Xiaofan Zheng
    • Pfizer Chet C. Tyrol, Doris Chen, Martin Bravo, Michael R. Collins, Raymond K. Twumasi
    • AbbVie Arianne C. Hunter, Kaid C. Harper
    • Enamine Pavel K. Mykhailiuk
    • Biogen Michael C. Nicastri, Philippe N. Bolduc
  4. Accelerating Medicinal Chemistry: A C(sp3)-Rich Fragment Toolbox for Redox-Neutral Cross-Coupling

    Angew. Chem. Int. Ed. 2025 · doi:10.1002/anie.202517207 · In our publications

    • Bristol Myers Squibb Jennifer Xiaoxin Qiao, Martins S. Oderinde, Maximilian D. Palkowitz, Megan A. Emmanuel
    • Pfizer Johnny W. Lee, Louise Bernier, Martin Bravo, Michael R. Collins, Neal W. Sach, Paul Richardson
    • Biogen Michael C. Nicastri, Philippe N. Bolduc, Shalini Dey
  5. Sulfonyl Hydrazides as a General Redox-Neutral Platform for Radical Cross-Coupling

    Science 2025 · doi:10.1126/science.adu6406 · In our publications

    • Bristol Myers Squibb Benjamin Vokits, David S. Peters, Martins S. Oderinde, Maximilian D. Palkowitz, Michael D. Mandler
    • Pfizer Doris Chen, Paul Richardson
  6. Electroreductive Synthesis of Nickel(0) Complexes

    Angew. Chem. Int. Ed. 2024 · doi:10.1002/anie.202311557 · In our publications

    • Bristol Myers Squibb Gregory L. Beutner, Steven R. Wisniewski
    • Syngenta Julien C. Vantourout
  7. Discovery of N–X Anomeric Amides as Electrophilic Halogenation Reagents

    Nat. Chem. 2024 · doi:10.1038/s41557-024-01539-4 · In our publications

    • Bristol Myers Squibb Jennifer Xiaoxin Qiao, Lauren N. Grant, Martins S. Oderinde, Maximilian D. Palkowitz, Shasha Zhang
    • Pfizer Chet C. Tyrol, Doris Chen, Erik LaChapelle, Lacey Samp, Michael R. Collins, Paul Richardson
    • AbbVie Aristidis Vasilopoulos, Kaid C. Harper
  8. Nickel-Electrocatalytic Decarboxylative Arylation to Access Quaternary Centers

    Angew. Chem. Int. Ed. 2024 · doi:10.1002/ange.202314617 · In our publications

    • Bristol Myers Squibb Daniel Ridge, Jack L. Sloane, Kevin W. Gillman, Martins S. Oderinde, Maximilian D. Palkowitz, Megan A. Emmanuel, Michael D. Mandler
    • LEO Pharma Nadia Nasser Petersen, Pablo Martín-Gago, Sebastian Clementson
    • Enamine Pavel K. Mykhailiuk
    • Biogen Michael C. Nicastri, Philippe N. Bolduc
  9. Simplifying Access to Targeted Protein Degraders via Nickel Electrocatalytic Cross-Coupling

    Angew. Chem. Int. Ed. 2024 · doi:10.1002/anie.202319856 · In our publications

    • Bristol Myers Squibb Andrew P. Degnan, Chi He, David S. Peters, Martins S. Oderinde, Megan A. Emmanuel
  10. Stereocontrolled Access to Thioisosteres of Nucleoside Di- and Triphosphates

    Nat. Chem. 2024 · doi:10.1038/s41557-023-01347-2 · In our publications

    • Bristol Myers Squibb Bin Zheng, Martin D. Eastgate, Michael A. Schmidt, Ziqin Lin
  11. Stereocontrolled Radical Thiophosphorylation

    J. Am. Chem. Soc. 2023 · doi:10.1021/jacs.3c05655 · In our publications

    • Bristol Myers Squibb Anthony N. Cauley, Bryan J. Simmons, Lauren N. Grant, Martin D. Eastgate, Martins S. Oderinde, Michael A. Schmidt
  12. Complex Molecule Synthesis by Electrocatalytic Decarboxylative Cross-Coupling

    Nature 2023 · doi:10.1038/s41586-023-06677-2 · In our publications

    • Bristol Myers Squibb Martins S. Oderinde, Maximilian D. Palkowitz, Michael D. Mandler, T. G. Murali Dhar
    • Pfizer Daniel C. Schmitt, Michael R. Collins
    • LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
    • Biogen Philippe N. Bolduc, TeYu Chen
    • Lilly Daniel C. Schmitt
  13. Enantioselective Total Synthesis of (+)-KB343

    J. Am. Chem. Soc. 2023 · doi:10.1021/jacs.3c01991 · In our publications

    • Bristol Myers Squibb Chi He
  14. Overcoming Limitations in Decarboxylative Arylation via Ag–Ni Electrocatalysis

    J. Am. Chem. Soc. 2022 · doi:10.1021/jacs.2c08006 · In our publications

    • Bristol Myers Squibb Benjamin Vokits, Hao Zhang, Jeremy M. Richter, Martins S. Oderinde, Michael A. Poss, Michael D. Mandler, Peter T. W. Cheng, Scott A. Shaw, T. G. Murali Dhar, Yeheng Zhu
    • Pfizer Martin Bravo, Michael R. Collins, Ryan Schioldager
    • LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
    • Enamine Pavel K. Mykhailiuk
    • Biogen Philippe N. Bolduc, TeYu Chen, Vanna D. Blasczak
    • Minakem Pierre-Georges Echeverria
  15. Ni-Electrocatalytic Csp3–Csp3 Doubly Decarboxylative Coupling

    Nature 2022 · doi:10.1038/s41586-022-04691-4 · In our publications

    • Bristol Myers Squibb Jennifer Xiaoxin Qiao, Martins S. Oderinde
  16. Nature Chose Phosphates and Chemists Should Too: How Emerging P(V) Methods Can Augment Existing Strategies

    ACS Cent. Sci. 2021 · doi:10.1021/acscentsci.1c00487 · In our publications

    • Bristol Myers Squibb Ivar M. McDonald, Martin D. Eastgate, Michael A. Schmidt
    • Elsie Biotechnologies Dillon T. Flood, Kyle W. Knouse
  17. Mild and Chemoselective Phosphorylation of Alcohols Using a Ψ-Reagent

    Org. Lett. 2021 · doi:10.1021/acs.orglett.1c02736 · In our publications

    • Bristol Myers Squibb Bin Zheng, Martin D. Eastgate, Michael A. Schmidt, Shenjie Qiu
  18. Chemoselective, Scalable Nickel-Electrocatalytic O-Arylation of Alcohols

    Angew. Chem. Int. Ed. 2021 · doi:10.1002/anie.202107820 · In our publications

    • Bristol Myers Squibb Jacob T. Edwards, Martins S. Oderinde
  19. Synthesis of a Phosphorous Sulfur Incorporating Reagent for the Enantioselective Synthesis of Thiophosphates

    Org. Synth. 2021 · doi:10.15227/orgsyn.098.0097 · In our publications

    • Bristol Myers Squibb Amitha S. Anandamurthy, Bin Zheng, Jason Zhu, Martin D. Eastgate, Michael A. Schmidt, Prantik Maity, Rajappa Vaidyanathan, Richard J. Fox, Vijaykumar Shekarappa
  20. A P(V) Platform for Oligonucleotide Synthesis

    Science 2021 · doi:10.1126/science.abi9727 · In our publications

    • Bristol Myers Squibb Bin Zheng, Ivar M. McDonald, Martin D. Eastgate, Michael A. Schmidt, Richard E. Olson, Shenjie Qiu, Stephen E. Mercer, Yazhong Huang
    • Elsie Biotechnologies Bin Zheng, Ivar M. McDonald, Kyle W. Knouse, Martin D. Eastgate, Michael A. Schmidt, Richard E. Olson, Shenjie Qiu, Stephen E. Mercer, Yazhong Huang
  21. Chemoselective Electrosynthesis Using Rapid Alternating Polarity

    J. Am. Chem. Soc. 2021 · doi:10.1021/jacs.1c06572 · In our publications

    • Bristol Myers Squibb Bryan J. Simmons, Christoph W. Zapf, Jacob T. Edwards
    • IKA Dirk Waldmann, Shobin Shaji
  22. N-Ammonium Ylide Mediators for Electrochemical C–H Oxidation

    J. Am. Chem. Soc. 2021 · doi:10.1021/jacs.1c03780 · In our publications

    • Bristol Myers Squibb Martin D. Eastgate, Michael A. Schmidt
    • Syngenta Bruce P. McKillican, Moses G. Gichinga, Sameer Tyagi
  23. Serine-Selective Bioconjugation

    J. Am. Chem. Soc. 2020 · doi:10.1021/jacs.0c05595 · In our publications

    • Bristol Myers Squibb Antonio Ramírez, Jennifer Xiaoxin Qiao, Martin D. Eastgate, Michael A. Schmidt
  24. Hindered Dialkyl Ether Synthesis with Electrogenerated Carbocations

    Nature 2019 · doi:10.1038/s41586-019-1539-y · In our publications

    • Bristol Myers Squibb Gregory L. Beutner
    • Pfizer Alyn Davies, Gary M. Gallego, Jeremy T. Starr, Jillian E. Spangler, Matthew Del Bel, Michael R. Collins, Shouliang Yang
    • Enamine Pavel K. Mykhailiuk
  25. A Radical Approach to Anionic Chemistry: Synthesis of Ketones, Alcohols, and Amines

    J. Am. Chem. Soc. 2019 · doi:10.1021/jacs.9b02238 · In our publications

    • Bristol Myers Squibb Robert J. Cherney
    • Pfizer Daniel C. Schmitt, Gary M. Gallego, James J. Mousseau, Matthew A. Perry, Michael R. Collins, Shouliang Yang
    • Enamine Pavel K. Mykhailiuk, Pavlo S. Lebed
  26. Direct Carbon Isotope Exchange through Decarboxylative Carboxylation

    J. Am. Chem. Soc. 2019 · doi:10.1021/jacs.8b12035 · In our publications

    • Bristol Myers Squibb Alban J. Allentoff, Michael A. Wallace, Samuel J. Bonacorsi, Sharon X. Gong
  27. A General Amino Acid Synthesis Enabled by Innate Radical Cross-Coupling

    Angew. Chem. Int. Ed. 2018 · doi:10.1002/anie.201809310 · In our publications

    • Bristol Myers Squibb David R. Langley, Jennifer Xiaoxin Qiao, K. -S. Yeung, Michael A. Poss, Paul M. Scola
    • Pfizer Daniel C. Schmitt, Gary M. Gallego, James J. Mousseau, Michael R. Collins, Shouliang Yang
  28. Unlocking P(V): Reagents for Chiral Phosphorothioate Synthesis

    Science 2018 · doi:10.1126/science.aau3369 · In our publications

    • Bristol Myers Squibb Bin Zheng, Changxia Yuan, Chao Hang, Ivar M. McDonald, Jason Zhu, Martin D. Eastgate, Michael A. Schmidt, Peter J. Park, Qinggang Wang, Richard E. Olson, Stephen E. Mercer, Ye Zhu
  29. CITU: A Peptide and Decarboxylative Coupling Reagent

    Org. Lett. 2017 · doi:10.1021/acs.orglett.7b03121 · In our publications

    • Bristol Myers Squibb Jason M. Stevens, Jennifer Xiaoxin Qiao, Martin P. Allen, Michael A. Poss
    • Asymchem Deng-Hui Bao, Guanda Che, Zhiqing Liu
  30. Decarboxylative Alkynylation

    Angew. Chem. Int. Ed. 2017 · doi:10.1002/anie.201705107 · In our publications

    • Bristol Myers Squibb Martin D. Eastgate, Scott A. Shaw
    • Asymchem Guanda Che, Zhiqing Liu, Zichao Shen
  31. Decarboxylative Alkenylation

    Nature 2017 · doi:10.1038/nature22307 · In our publications

    • Bristol Myers Squibb Benjamin Vokits, Martin D. Eastgate, Scott A. Shaw
    • Asymchem Deng-Hui Bao, Fu-Liang Wei, Ting Zhou
  32. Peptide Macrocyclization Inspired by Non-Ribosomal Imine Natural Products

    J. Am. Chem. Soc. 2017 · doi:10.1021/jacs.7b01624 · In our publications

    • Bristol Myers Squibb Kevin J. Robbins, Martin D. Eastgate, Paul M. Scola
  33. Redox-Active Esters in Fe-Catalyzed C–C Coupling

    J. Am. Chem. Soc. 2016 · doi:10.1021/jacs.6b07172 · In our publications

    • Bristol Myers Squibb Darryl D. Dixon, Gardner S. Creech
  34. Nickel-Catalyzed Cross-Coupling of Redox-Active Esters with Boronic Acids

    Angew. Chem. Int. Ed. 2016 · doi:10.1002/anie.201605463 · In our publications

    • Bristol Myers Squibb Benjamin Vokits, Scott A. Shaw
  35. Scalable and Sustainable Electrochemical Allylic C–H Oxidation

    Nature 2016 · doi:10.1038/nature17431 · In our publications

    • Bristol Myers Squibb Ke Chen, Martin D. Eastgate
    • Asymchem Jiaze Tang, Yong Chen
  36. Practical Ni-Catalyzed Aryl–Alkyl Cross-Coupling of Secondary Redox-Active Esters

    J. Am. Chem. Soc. 2016 · doi:10.1021/jacs.6b00250 · In our publications

    • Bristol Myers Squibb Martin D. Eastgate, Michael A. Schmidt
  37. Antroquinonol A: Scalable Synthesis and Preclinical Biology of a Phase 2 Drug Candidate

    ACS Cent. Sci. 2016 · doi:10.1021/acscentsci.5b00345 · In our publications

    • Bristol Myers Squibb Haiying Zhang, Joseph Fargnoli, Kathy Johnston, Mark Fereshteh, R. M. Borzilleri, T. G. Murali Dhar
  38. Hydromethylation of Unactivated Olefins

    J. Am. Chem. Soc. 2015 · doi:10.1021/jacs.5b05144 · In our publications

    • Bristol Myers Squibb Brad D. Maxwell
  39. Practical Olefin Hydroamination with Nitroarenes

    Science 2015 · doi:10.1126/science.aab0245 · In our publications

    • Bristol Myers Squibb Michael A. Schmidt, Michael Mertzman, Steven H. Spergel, Thomas E. La Cruz, William J. Pitts
    • Kemxtree Nitin B. Darvatkar, Swaminathan R. Natarajan
  40. Improving Physical Properties via C-H Oxidation: Chemical and Enzymatic Approaches

    Angew. Chem. Int. Ed. 2014 · doi:10.1002/anie.201407016 · In our publications

    • Bristol Myers Squibb Alicia Regueiro-Ren, Animesh Goswami, Thomas P. Tully, Zhiwei Guo
  41. Palau’chlor: A Practical and Reactive Chlorinating Reagent

    J. Am. Chem. Soc. 2014 · doi:10.1021/ja5031744 · In our publications

    • Bristol Myers Squibb Martin D. Eastgate
  42. A Mild, Ferrocene-Catalyzed C–H Imidation of (Hetero)Arenes

    J. Am. Chem. Soc. 2014 · doi:10.1021/ja501879c · In our publications

    • Bristol Myers Squibb Martin D. Eastgate
  43. Natural Product Synthesis in the Age of Scalability

    Nat. Prod. Rep. 2014 · doi:10.1039/C3NP70090A · In our publications

    • Bristol Myers Squibb Martin D. Eastgate
  44. Regioselective Bromination of Fused Heterocyclic N-Oxides

    Org. Lett. 2013 · doi:10.1021/ol3034675 · In our publications

    • Bristol Myers Squibb Ke Chen, Martin D. Eastgate, Neil A. Strotman

Our co-authors at Bristol Myers Squibb

Martin P. AllenAlban J. AllentoffAmitha S. AnandamurthyGregory L. BeutnerSamuel J. BonacorsiR. M. BorzilleriAnthony N. CauleyMichael ChanKe ChenPeter T. W. ChengEmily C. CherneyRobert J. CherneyYounhee ChoGardner S. CreechThomas E. La CruzAndrew P. DegnanT. G. Murali DharDrexler DieterDarryl D. DixonMartin D. EastgateJacob T. EdwardsMonir EjemelMegan A. EmmanuelHelen L. EvansJoseph FargnoliMark FereshtehRichard J. FoxKevin W. GillmanSharon X. GongAnimesh GoswamiLauren N. GrantZhiwei GuoChao HangChi HeYazhong HuangKathy JohnstonNicole Vincent JordanJuhi JunejaDavid R. LangleyEmily LeeAiling LiZiqin LinPrantik MaityMichael D. MandlerBrad D. MaxwellIvar M. McDonaldStephen E. MercerMichael MertzmanDonggeon NamMartins S. OderindeRichard E. OlsonMaximilian D. PalkowitzPeter J. ParkZach ParsonsDavid S. PetersWilliam J. PittsMichael A. PossJennifer Xiaoxin QiaoShenjie QiuAntonio RamírezAlicia Regueiro-RenJeremy M. RichterDaniel RidgeKevin J. RobbinsMichael A. SchmidtPaul M. ScolaScott A. ShawVijaykumar ShekarappaBryan J. SimmonsJack L. SloaneSteven H. SpergelJason M. StevensNeil A. StrotmanRuchita Rajendra ThakoreThomas P. TullyRajappa VaidyanathanBenjamin VokitsMichael A. WallaceWade WangQinggang WangEric R. WelinSteven R. WisniewskiSayumi YamazoeK. -S. YeungChangxia YuanChristoph W. ZapfHong ZhangShasha ZhangHao ZhangHaiying ZhangBin ZhengXiaofan ZhengYaxing ZhuYeheng ZhuJason ZhuYe Zhu

Some of these papers were shared with 13 other partners: Chemveda Life Sciences, Pfizer, AbbVie, Enamine, Biogen, Syngenta, LEO Pharma, Eli Lilly and Company, Minakem, Elsie Biotechnologies, IKA, Asymchem, Kemxtree.

Work with us

Interested in collaborating with the Baran lab?

If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.

Email Phil

or write to pbaran@scripps.edu